Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Johnson and Johnson
Merck
Baxter
AstraZeneca

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tenecteplase

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Tenecteplase: Sponsors, patents, clinical trial progress

Tenecteplase is an investigational drug.

There have been 45 clinical trials for Tenecteplase. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2003.

The most common disease conditions in clinical trials are Infarction, Myocardial Infarction, and Stroke. The leading clinical trial sponsors are Boehringer Ingelheim, Genentech, Inc., and University of Calgary.

Recent Clinical Trials for Tenecteplase
TitleSponsorPhase
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -TenecteplaseShanghai 6th People's HospitalPhase 2
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -TenecteplaseThe First Affiliated Hospital of Zhengzhou UniversityPhase 2
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -TenecteplaseHuashan HospitalPhase 2

See all Tenecteplase clinical trials

Clinical Trial Summary for Tenecteplase

Top disease conditions for Tenecteplase
Top clinical trial sponsors for Tenecteplase

See all Tenecteplase clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Dow
Medtronic
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.